Back to top

Image: Bigstock

Canopy Growth (CGC) in Focus: Stock Moves 6.4% Higher

Read MoreHide Full Article

Canopy Growth Corporation (CGC - Free Report) was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $13.56 to $17.53 in the past one-month time frame.

The company has seen one positive estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Canopy Growth. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Canopy Growth currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.  

Canopy Growth Corporation Price

Investors interested in the Medical - Products industry may consider Bovie Medical Corporation (APYX - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Canopy Growth Corporation (CGC) - free report >>

Bovie Medical Corporation (APYX) - free report >>